• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00532220
Medical Device Problem Codes Problem with Sterilization (1596); Contamination /Decontamination Problem (2895)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/25/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.It was reported the device was not used past its expiry.Initial reporter state - (b)(6).(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event or Problem Description
It was reported to boston scientific corporation that a previously implanted advanix biliary stent was removed from a patient during a planned biliary stent procedure performed in the biliary tract on (b)(6) 2020.On (b)(6) 2020 the advanix biliary stent was placed in the patient with no issues reported during placement of the device.This complaint is being reported to address the device deficiency experienced on (b)(6) 2020.According to the complainant, on (b)(6) 2020 during the planned stent removal procedure, the physician attempted to pull out the advanix biliary stent in order to insert a metallic stent in its place, however, the advanix biliary stent became damaged during attempted removal.The removal and extraction attempts were repeated several times with a snare and grasping forceps, but during this time the stent was broken.As a result, it was determined that all the pieces of the broken stent had been removed from the patient and the procedure was completed with no patient complications reported.This endoscope was allegedly cleaned, disinfected and stored after the procedure.Two days later on (b)(6) 2020, the physician was using the same endoscope that was used during the stent removal procedure on (b)(6) 2020 on another patient.While inside the patient with the endoscope, a fragment that appeared to be part of a tube stent was found in the second patient's body and was then removed.Sources pointed out that the fragment was probably part of the advanix biliary stent that was removed from a separate patient on (b)(6) 2020 using this endoscope.As of (b)(6) 2020 there were no adverse effect attributed to this event to any of the patient's health involved in these procedures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANIX BILIARY
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key9922365
Report Number3005099803-2020-01467
Device Sequence Number3272479
Product Code FGE
UDI-Device Identifier08714729787006
UDI-Public08714729787006
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K101786
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM00532220
Device Catalogue Number3222
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/10/2020
Initial Report FDA Received Date04/03/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-